Summary: LSD microdoses (13 μg and 26 μg) changed psychological and behavioral functioning, but the effects were relatively modest and many areas of functioning were not altered at all. Microdosing did not have a positive effect on cognitive performance. Authors: Anya K. Bershad, Scott T. Schepers, Michael P. Bremmer, Royce Lee, Harriet de Wit DOI: 10.1016/j.biopsych.2019.05.019 […]
Read MoreSeth
![Dr. Rick Barnett](https://thedrugclassroom.com/wp-content/uploads/2019/10/Thumbnails-750x422.jpg)
TDC Podcast 14 – Dr. Rick Barnett on Addiction Treatment and Why Psychologists Should Be Prescribers
Dr. Rick Barnett is a psychologist with a doctorate in psychology and a master’s degree in clinical psychopharmacology. He owns a private mental health practice in Vermont called BPS Health, LLC and is also President-Elect of the American Psychology Association’s Division 55 (American Society for the Advancement of Pharmacotherapy). He is currently advocating in support […]
Read More![Zach Rhoads](https://thedrugclassroom.com/wp-content/uploads/2019/05/site-750x422.jpg)
Zach Rhoads is a counselor who works with families and children. Along with the psychologist Stanton Peele he has coauthored Outgrowing Addiction, a new book that explains why a developmental model of the disorder makes more sense than the disease model. The book draws on Zach’s personal experience with addiction and on his work with […]
Read More![Hamilton Morris](https://thedrugclassroom.com/wp-content/uploads/2018/12/Site-750x422.jpg)
Hamilton Morris is a journalist and scientific researcher known for his documentaries, particularly those in the series Hamilton’s Pharmacopeia, which is available through iTunes, Google Play, Hulu, and more. He has also written a number of articles for Harpers, which can be found here: https://harpers.org/author/hamiltonmorris/ In this episode we cover a range of topics, from sacred […]
Read More![TDC podcast Dr. Mark Lysyshyn](https://thedrugclassroom.com/wp-content/uploads/2018/11/Thumbnail-750x422.jpg)
Dr. Mark Lysyshyn is a medical health officer with Vancouver Coastal Health in British Columbia, Canada. The Vancouver region, like many parts of North America, has been strongly affected by the rise in opioid-related fatalities. Dr. Lysyshyn is among those working to reduce fatalities by researching and expanding harm reduction tools. He recently co-authored a […]
Read More![TDC Podcast Brad Burge](https://thedrugclassroom.com/wp-content/uploads/2018/08/Thumbnail-750x422.jpg)
Brad Burge is the Director of Communications at the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a leading organization in the field of psychedelic research and it has been particularly focused on MDMA-assisted psychotherapy, largely for PTSD. MDMA appears to be very useful in the treatment of PTSD. A couple therapy sessions with the […]
Read More![antidepressants](https://thedrugclassroom.com/wp-content/uploads/2018/04/Site-750x422.jpg)
Summary: 522 randomized controlled trials involving 21 antidepressants and 116,477 people were analyzed. It appears the most effective antidepressants (at a duration of 8 weeks) include amitriptyline, escitalopram, mirtazapine, paroxetine, and venlafaxine. While reboxetine and trazodone had notably lower efficacy ratings. Some of the most effective drugs had lower tolerability scores, however, indicating they may […]
Read More![Guy Jones](https://thedrugclassroom.com/wp-content/uploads/2018/02/Thumbnail-750x422.jpg)
Guy Jones runs Reagent Tests UK and is a senior chemist for The Loop, a drug checking organization in the UK. He’s also associated with Kosmicaid, a group that offers psychedelic harm reduction services at music events. Drug checking involves analyzing a substance with tools like reagent liquids and GC/MS in order to gain a […]
Read More![Lyn Ulbricht - Silk Road - Ross Ulbricht](https://thedrugclassroom.com/wp-content/uploads/2017/11/Thumbnail-750x422.jpg)
Ross Ulbricht, the founder of Silk Road, an online Bitcoin-based marketplace, was arrested in 2013. The authorities primarily targeted him due to the actions of Silk Road’s users, who frequently utilized the site for drug transactions. Ulbricht was eventually sentenced to life in prison, highlighting potentially severe problems in the justice system. The case touches […]
Read More![](https://thedrugclassroom.com/wp-content/uploads/2017/10/Site-1-750x422.jpg)
TDC abstract: Psilocybin, a prodrug for psilocin, appears to have detectable effects on brain activity the day after an experience in those with treatment-resistant depression. There’s a rise in functional connectivity within the default mode network (DMN) and a decline in functional connectivity between the parahippocampus and prefrontal cortex. Authors: Robin L Carhart-Harris, Leor Roseman, Mark […]
Read More![](https://thedrugclassroom.com/wp-content/uploads/2017/10/Thumbnail-750x422.jpg)
Christopher Moraff is a journalist based in Philadelphia, Pennsylvania. He’s covered the drug war and the regional impact of drug prohibition. He writes for The Daily Beast, NextCity.org, and The Crime Report. In this episode we discuss fentanyl’s impact on the Philadelphia drug market, prohibition, the “opioid epidemic,” and local policies, among other things. Twitter […]
Read More![](https://thedrugclassroom.com/wp-content/uploads/2017/09/Thumbnail-750x422.jpg)
David Juurlink is a physician, pharmacologist, and drug safety researcher. He’s affiliated with the Institute for Clinical Evaluative Sciences (ICES), the University of Toronto, Sunnybrook Research Institute, and Sunnybrook Health Sciences Centre. Though he deals with many drug classes in his daily work, his perspectives on opioid prescribing and the “opioid epidemic” in particular have received a […]
Read More